Hospital do RIM - UNIFESP

São Paulo 04023-062

0 studies enrolling now · 2 studies all time

What they study most

Kidney Disease, Chronic, Scleroderma, Systemic

Studies at this site

• A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms — Completed
• A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease — Completed